Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants

By Montané Jaime Lazara Karelia   Lalla Anthony   Steimer Werner   Gaedigk Andrea  

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 261-276

Future Medicine

Access to resources Recommend Favorite

Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

By Mitchell Cathrine   Gregersen Nerine   Krause Amanda  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 953-963

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic Screening of the Gene Deletion and Duplications of CYP2D6

By Meijerman Irma   Sanderson Linda   Smits Paul   Beijnen Jos   Schellens Jan  

Drug Metabolism Reviews, Vol. 39, Iss. 1, 2007-01 ,pp. : 45-60

Informa Healthcare

Access to resources Recommend Favorite

Allelic Variations in CYP2D6 Gene and Susceptibility to Cervical Cancer

By  

Drug Metabolism Letters, Vol. 1, Iss. 4, 2007-12 ,pp. : 276-280

Bentham Science Publishers

Access to resources Recommend Favorite

CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene

By Skierka Jennifer M   Walker Denise L   Peterson Sandra E   O’Kane Dennis J   Black John Logan  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 951-954

Future Medicine

Access to resources Recommend Favorite